Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

References

• Olds H, Liu J, Luk K, Lim HW, Ozog D, Rambhatla PV. Telogen effluvium associated with COVID-19 infection. Dermatol Ther. 2021;34(2):e14761. doi:10.1111/dth.14761
   PubMed Web of Science ®Google Scholar
• Sharquie KE, Jabbar RI. COVID-19 infection is a major cause of acute telogen effluvium. Ir J Med Sci. 2021. doi:10.1007/s11845-021-02754-5
   PubMed Web of Science ®Google Scholar
• Christensen RE, Jafferany M. Association between alopecia areata and COVID-19: a systematic review. JAAD Int. 2022;7:57–61. doi:10.1016/j.jdin.2022.02.002
   PubMedGoogle Scholar
• Wambier CG, Vano-Galvan S, McCoy J, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: the “Gabrin sign”. J Am Acad Dermatol. 2020;83(2):680–682. doi:10.1016/j.jaad.2020.05.079
   PubMed Web of Science ®Google Scholar
• Goren A, McCoy J, Wambier CG, et al. What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy. Dermatol Ther. 2020;33(4):e13365. doi:10.1111/dth.13365
   PubMed Web of Science ®Google Scholar
• Wambier CG, Goren A, Vano-Galvan S, et al. Androgen sensitivity gateway to COVID-19 disease severity. Drug Dev Res. 2020;81(7):771–776. doi:10.1002/ddr.21688
   PubMed Web of Science ®Google Scholar
• Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi:10.1016/S0140-6736(20)32656-8
   PubMed Web of Science ®Google Scholar
• Starace M, Iorizzo M, Sechi A, et al. Trichodynia and telogen effluvium in COVID-19 patients: results of an international expert opinion survey on diagnosis and management. JAAD Int. 2021;5:11–18. doi:10.1016/j.jdin.2021.07.006
   PubMedGoogle Scholar
• Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med. 2020;8(6):e46–e47. doi:10.1016/S2213-2600(20)30216-2
   PubMed Web of Science ®Google Scholar
• Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, et al. SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol. 2021;35(3):e181–e183. doi:10.1111/jdv.17045
   PubMed Web of Science ®Google Scholar
• Kutlu O, Metin A. Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID-19 pandemic. Dermatol Ther. 2020;33(6):e14096. doi:10.1111/dth.14096
   PubMed Web of Science ®Google Scholar
• Reid EE, Haley AC, Borovicka JH, et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia. J Am Acad Dermatol. 2012;66(3):e97–102. doi:10.1016/j.jaad.2010.11.042
   PubMed Web of Science ®Google Scholar
• Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: a review of the literature. Cureus. 2020;12(5):e8320. doi:10.7759/cureus.8320
   PubMed Web of Science ®Google Scholar
• Rivetti N, Barruscotti S. Management of telogen effluvium during the COVID-19 emergency: psychological implications. Dermatol Ther. 2020;33(4):e13648. doi:10.1111/dth.13648
   PubMed Web of Science ®Google Scholar
• Violant-Holz V, Gallego-Jimenez MG, Gonzalez-Gonzalez CS, et al. Psychological health and physical activity levels during the COVID-19 pandemic: a systematic review. Int J Environ Res Public Health. 2020;17(24):9419. doi:10.3390/ijerph17249419
   PubMed Web of Science ®Google Scholar
• Abrantes TF, Artounian KA, Falsey R, et al. Time of onset and duration of post-COVID-19 acute telogen effluvium. J Am Acad Dermatol. 2021;85(4):975–976. doi:10.1016/j.jaad.2021.07.021
   PubMed Web of Science ®Google Scholar
• Trueb RM. Systematic approach to hair loss in women. J Dtsch Dermatol Ges. 2010;8(4):284–297, 284–298. doi:10.1111/j.1610-0387.2010.07261.x
   PubMed Web of Science ®Google Scholar
• Mieczkowska K, Deutsch A, Borok J, et al. Telogen effluvium: a sequela of COVID-19. Int J Dermatol. 2021;60(1):122–124. doi:10.1111/ijd.15313
   PubMed Web of Science ®Google Scholar
• Hoier A, Chaaban N, Andersen BV. Possibilities for maintaining appetite in recovering COVID-19 patients. Foods. 2021;10(2):464. doi:10.3390/foods10020464
   PubMed Web of Science ®Google Scholar
• Calder PC. Nutrition, immunity and COVID-19. BMJ Nutr Prev Health. 2020;3(1):74–92. doi:10.1136/bmjnph-2020-000085
   PubMedGoogle Scholar
• Gombart AF, Pierre A, Maggini S. A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients. 2020;12(1):236. doi:10.3390/nu12010236
   PubMed Web of Science ®Google Scholar
• Hamulka J, Jeruszka-Bielak M, Gornicka M, Drywien ME, Zielinska-Pukos MA. Dietary supplements during COVID-19 outbreak. Results of google trends analysis supported by PLifeCOVID-19 online studies. Nutrients. 2020;13(1):54. doi:10.3390/nu13010054
   PubMed Web of Science ®Google Scholar
• Adelman MJ, Bedford LM, Potts GA. Clinical efficacy of popular oral hair growth supplement ingredients. Int J Dermatol. 2021;60(10):1199–1210. doi:10.1111/ijd.15344
   PubMed Web of Science ®Google Scholar
• Cheung EJ, Sink JR, English JC III. Vitamin and mineral deficiencies in patients with telogen effluvium: a retrospective cross-sectional study. J Drugs Dermatol. 2016;15(10):1235–1237.
   PubMed Web of Science ®Google Scholar
• Gerkowicz A, Chyl-Surdacka K, Krasowska D, Chodorowska G. The role of vitamin D in non-scarring alopecia. Int J Mol Sci. 2017;18(12):2653. doi:10.3390/ijms18122653
   PubMed Web of Science ®Google Scholar
• Nayak K, Garg A, Mithra P, Manjrekar P. Serum vitamin D3 levels and diffuse hair fall among the student population in south India: a case-control study. Int J Trichology. 2016;8(4):160–164. doi:10.4103/ijt.ijt_57_16
   PubMedGoogle Scholar
• Demay MB. The hair cycle and vitamin D receptor. Arch Biochem Biophys. 2012;523(1):19–21. doi:10.1016/j.abb.2011.10.002
   PubMed Web of Science ®Google Scholar
• Vimaleswaran KS, Forouhi NG, Khunti K. Vitamin D and covid-19. BMJ. 2021;372:n544. doi:10.1136/bmj.n544
   PubMed Web of Science ®Google Scholar
• Beoy LA, Woei WJ, Hay YK. Effects of tocotrienol supplementation on hair growth in human volunteers. Trop Life Sci Res. 2010;21(2):91–99.
   PubMedGoogle Scholar
• Patel DP, Swink SM, Castelo-Soccio L. A review of the use of biotin for hair loss. Skin Appendage Disord. 2017;3(3):166–169. doi:10.1159/000462981
   PubMed Web of Science ®Google Scholar
• Plonka PM, Handjiski B, Popik M, Michalczyk D, Paus R. Zinc as an ambivalent but potent modulator of murine hair growth in vivo- preliminary observations. Exp Dermatol. 2005;14(11):844–853. doi:10.1111/j.1600-0625.2005.00365.x
   PubMed Web of Science ®Google Scholar
• Kil MS, Kim CW, Kim SS. Analysis of serum zinc and copper concentrations in hair loss. Ann Dermatol. 2013;25(4):405–409. doi:10.5021/ad.2013.25.4.405
   PubMed Web of Science ®Google Scholar
• Siavash M, Tavakoli F, Mokhtari F. Comparing the effects of zinc sulfate, calcium pantothenate, their combination and minoxidil solution regimens on controlling hair loss in women: a randomized controlled trial. J Res Pharm Pract. 2017;6(2):89–93. doi:10.4103/jrpp.JRPP_17_17
   PubMed Web of Science ®Google Scholar
• Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The role of vitamins and minerals in hair loss: a review. Dermatol Ther (Heidelb). 2019;9(1):51–70. doi:10.1007/s13555-018-0278-6
   PubMed Web of Science ®Google Scholar
• Coad J, Conlon C. Iron deficiency in women: assessment, causes and consequences. Curr Opin Clin Nutr Metab Care. 2011;14(6):625–634. doi:10.1097/MCO.0b013e32834be6fd
   PubMed Web of Science ®Google Scholar
• Rasheed H, Mahgoub D, Hegazy R, et al. Serum ferritin and vitamin d in female hair loss: do they play a role? Skin Pharmacol Physiol. 2013;26(2):101–107. doi:10.1159/000346698
   PubMed Web of Science ®Google Scholar
• Poonia K, Thami GP, Bhalla M, Jaiswal S, Sandhu J. NonScarring diffuse hair loss in women: a clinico-etiological study from tertiary care center in North-West India. J Cosmet Dermatol. 2019;18(1):401–407. doi:10.1111/jocd.12559
   PubMed Web of Science ®Google Scholar
• Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824–844. doi:10.1016/j.jaad.2005.11.1104
   PubMed Web of Science ®Google Scholar
• Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol. 2002;27(5):396–404. doi:10.1046/j.1365-2230.2002.01076.x
   PubMed Web of Science ®Google Scholar
• Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med. 2004;351(15):1548–1563. doi:10.1056/NEJMcpc049016
   PubMed Web of Science ®Google Scholar
• Suleria HA, Osborne S, Masci P, Gobe G. Marine-based nutraceuticals: an innovative trend in the food and supplement industries. Mar Drugs. 2015;13(10):6336–6351. doi:10.3390/md13106336
   PubMed Web of Science ®Google Scholar
• Ablon G, Kogan S. A six-month, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of a nutraceutical supplement for promoting hair growth in women with self-perceived thinning hair. J Drugs Dermatol. 2018;17(5):558–565.
   PubMed Web of Science ®Google Scholar
• Rizer RL, Stephens TJ, Herndon JH, Sperber BR, Murphy J, Ablon GR. A marine protein-based dietary supplement for subclinical hair thinning/loss: results of a multisite, double-blind, placebo-controlled clinical trial. Int J Trichology. 2015;7(4):156–166. doi:10.4103/0974-7753.171573
   PubMedGoogle Scholar
• Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777–2786. doi:10.2147/DDDT.S214907
   PubMed Web of Science ®Google Scholar
• Mysore V, Parthasaradhi A, Kharkar RD, et al. Expert consensus on the management of Telogen Effluvium in India. Int J Trichology. 2019;11(3):107–112. doi:10.4103/ijt.ijt_23_19
   PubMedGoogle Scholar
• Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med. 2007;146(10):726–734. doi:10.7326/0003-4819-146-10-200705150-00006
   PubMed Web of Science ®Google Scholar
• Panahi Y, Taghizadeh M, Marzony ET, Sahebkar A. Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial. Skinmed. 2015;13(1):15–21.
   PubMedGoogle Scholar
• Konda D, Thappa DM. Mesotherapy: what is new? Indian J Dermatol Venereol Leprol. 2013;79(1):127–134. doi:10.4103/0378-6323.104689
   PubMed Web of Science ®Google Scholar
• Fertig RM, Gamret AC, Cervantes J, Tosti A. Microneedling for the treatment of hair loss? J Eur Acad Dermatol Venereol. 2018;32(4):564–569. doi:10.1111/jdv.14722
   PubMed Web of Science ®Google Scholar
• Carloni R, Pechevy L, Postel F, Zielinski M, Gandolfi S. Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: a systematic review of the literature. J Plast Reconstr Aesthet Surg. 2020;73(12):2210–2216. doi:10.1016/j.bjps.2020.05.035
   PubMed Web of Science ®Google Scholar
• Popescu MN, Petca RC, Beiu C, et al. Efficiency of different preparations of botulinum toxin type A, Xeomin and Dysport, in the management of spastic upper limb after stroke. Rev Chim. 2019;70(10):3490–3494. doi:10.37358/RC.19.10.7582
   Web of Science ®Google Scholar
• Carruthers A. Botulinum toxin type A: history and current cosmetic use in the upper face. Dis Mon. 2002;48(5):299–322. doi:10.1053/mda.2001.25138
   PubMed Web of Science ®Google Scholar
• Martina E, Diotallevi F, Radi G, Campanati A, Offidani A. Therapeutic use of botulinum neurotoxins in dermatology: systematic review. Toxins (Basel). 2021;13(2):120. doi:10.3390/toxins13020120
   PubMed Web of Science ®Google Scholar
• Jung BH, Song SH, Yoon SJ, Koo JH, Yoo KY. The effect of botulinum toxin on hair follicle cell regeneration under continuous stress conditions: a pilot animal study. Neurotox Res. 2022;40(1):103–110. doi:10.1007/s12640-021-00453-8
   PubMed Web of Science ®Google Scholar
• Gentile P, Scioli MG, Bielli A, et al. Platelet-rich plasma and micrografts enriched with autologous human follicle mesenchymal stem cells improve hair re-growth in androgenetic alopecia. biomolecular pathway analysis and clinical evaluation. Biomedicines. 2019;7(2):27. doi:10.3390/biomedicines7020027
   PubMed Web of Science ®Google Scholar
• Roohaninasab M, Goodarzi A, Ghassemi M, Sadeghzadeh-Bazargan A, Behrangi E, Najar Nobari N. Systematic review of platelet-rich plasma in treating alopecia: focusing on efficacy, safety, and therapeutic durability. Dermatol Ther. 2021;34(2):e14768. doi:10.1111/dth.14768
   PubMed Web of Science ®Google Scholar
• Popescu MN, Iliescu MG, Beiu C, et al. Autologous platelet-rich plasma efficacy in the field of regenerative medicine: product and quality control. Biomed Res Int. 2021;2021:4672959. doi:10.1155/2021/4672959
   PubMed Web of Science ®Google Scholar
• Islek A, Karaaslan E, Simsek S, Merve Cetin F. Platelet-rich plasma treatment for accelerated androgenetic alopecia pattern hair loss after COVID-19 infection: a case series. J Cosmet Dermatol. 2022;21(2):590–594. doi:10.1111/jocd.14721
   PubMed Web of Science ®Google Scholar